Omnicell, Inc. (OMCL)
USD 44.18
(-2.28%)
USD 44.18
(-2.28%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 614.09 Million USD | -0.43% |
| 2022 | 616.73 Million USD | 16.79% |
| 2021 | 528.06 Million USD | 2.32% |
| 2020 | 516.09 Million USD | 412.67% |
| 2019 | 100.66 Million USD | -25.66% |
| 2018 | 135.41 Million USD | -35.55% |
| 2017 | 210.12 Million USD | -17.32% |
| 2016 | 254.14 Million USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | -100.0% |
| 2005 | 11.15 Million USD | 246.12% |
| 2004 | 3.22 Million USD | 957.05% |
| 2003 | 305 Thousand USD | -79.69% |
| 2002 | 1.5 Million USD | 313.77% |
| 2001 | 363 Thousand USD | -95.69% |
| 2000 | 8.41 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 615.55 Million USD | 0.24% |
| 2024 Q3 | 603.52 Million USD | -0.21% |
| 2024 Q2 | 615.42 Million USD | -0.02% |
| 2023 Q2 | 603.62 Million USD | -0.09% |
| 2023 Q1 | 604.19 Million USD | -2.03% |
| 2023 Q4 | 614.09 Million USD | 2.05% |
| 2023 Q3 | 601.73 Million USD | -0.31% |
| 2023 FY | 614.09 Million USD | -0.43% |
| 2022 Q2 | 620.29 Million USD | 3.12% |
| 2022 Q1 | 601.54 Million USD | 13.91% |
| 2022 Q3 | 618.32 Million USD | -0.32% |
| 2022 Q4 | 616.73 Million USD | -0.26% |
| 2022 FY | 616.73 Million USD | 16.79% |
| 2021 FY | 528.06 Million USD | 2.32% |
| 2021 Q1 | 517.78 Million USD | 0.33% |
| 2021 Q2 | 520.06 Million USD | 0.44% |
| 2021 Q3 | 523.25 Million USD | 0.61% |
| 2021 Q4 | 528.06 Million USD | 0.92% |
| 2020 FY | 516.09 Million USD | 412.67% |
| 2020 Q1 | 48.85 Million USD | -51.47% |
| 2020 Q2 | 46.69 Million USD | -4.42% |
| 2020 Q3 | 506.48 Million USD | 984.77% |
| 2020 Q4 | 516.09 Million USD | 1.9% |
| 2019 Q1 | 154.46 Million USD | 14.06% |
| 2019 FY | 100.66 Million USD | -25.66% |
| 2019 Q2 | 131.79 Million USD | -14.67% |
| 2019 Q3 | 129.87 Million USD | -1.46% |
| 2019 Q4 | 100.66 Million USD | -22.49% |
| 2018 FY | 135.41 Million USD | -35.55% |
| 2018 Q4 | 135.41 Million USD | -26.74% |
| 2018 Q3 | 184.84 Million USD | -7.01% |
| 2018 Q2 | 198.77 Million USD | -4.53% |
| 2018 Q1 | 208.19 Million USD | -0.92% |
| 2017 Q3 | 192.33 Million USD | -1.08% |
| 2017 Q4 | 210.12 Million USD | 9.25% |
| 2017 FY | 210.12 Million USD | -17.32% |
| 2017 Q1 | 214.53 Million USD | -15.58% |
| 2017 Q2 | 194.43 Million USD | -9.37% |
| 2016 Q1 | 227.45 Million USD | 0.0% |
| 2016 Q3 | 223.24 Million USD | -0.93% |
| 2016 FY | 254.14 Million USD | 0.0% |
| 2016 Q2 | 225.34 Million USD | -0.93% |
| 2016 Q4 | 254.14 Million USD | 13.84% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2006 Q4 | - USD | -100.0% |
| 2006 Q3 | 1.13 Million USD | 35.94% |
| 2006 Q2 | 832 Thousand USD | -77.4% |
| 2006 FY | - USD | -100.0% |
| 2006 Q1 | 3.68 Million USD | -67.0% |
| 2005 FY | 11.15 Million USD | 246.12% |
| 2005 Q1 | 2.85 Million USD | -11.54% |
| 2005 Q2 | 2.23 Million USD | -21.67% |
| 2005 Q3 | 1.65 Million USD | -26.1% |
| 2005 Q4 | 11.15 Million USD | 575.89% |
| 2004 Q4 | 3.22 Million USD | -0.71% |
| 2004 Q3 | 3.24 Million USD | -14.71% |
| 2004 FY | 3.22 Million USD | 957.05% |
| 2004 Q2 | 3.8 Million USD | -12.52% |
| 2004 Q1 | 4.35 Million USD | 1326.89% |
| 2003 Q2 | 908 Thousand USD | -24.58% |
| 2003 Q3 | 608 Thousand USD | -33.04% |
| 2003 Q4 | 305 Thousand USD | -49.84% |
| 2003 FY | 305 Thousand USD | -79.69% |
| 2003 Q1 | 1.2 Million USD | -19.84% |
| 2002 Q3 | 1.79 Million USD | 0.0% |
| 2002 FY | 1.5 Million USD | 313.77% |
| 2002 Q2 | - USD | 0.0% |
| 2002 Q1 | - USD | -100.0% |
| 2002 Q4 | 1.5 Million USD | -16.42% |
| 2001 FY | 363 Thousand USD | -95.69% |
| 2001 Q4 | 363 Thousand USD | 0.0% |
| 2001 Q3 | - USD | -100.0% |
| 2001 Q2 | 11.39 Million USD | 35.64% |
| 2001 Q1 | 8.4 Million USD | 0.0% |
| 2000 FY | 8.41 Million USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Inovalon Holdings, Inc. | 897.3 Million USD | 31.563% |
| GE HealthCare Technologies Inc. | 9.86 Billion USD | 93.774% |
| Sharecare, Inc. | 2.34 Million USD | -26087.207% |
| Progyny, Inc. | 19.39 Million USD | -3067.045% |
| Aclarion, Inc. | 1.12 Million USD | -54450.671% |
| CareMax, Inc. | 491.93 Million USD | -24.832% |
| Simulations Plus, Inc. | 475 Thousand USD | -129182.105% |
| CareCloud, Inc. | 14.73 Million USD | -4068.126% |
| Forian Inc. | 23 Million USD | -2569.75% |
| Bullfrog AI Holdings, Inc. Warrants | - USD | -Infinity% |
| Bullfrog AI Holdings, Inc. Common Stock | - USD | -Infinity% |
| Minerva Surgical, Inc. | 39.69 Million USD | -1447.216% |
| Definitive Healthcare Corp. | 267.92 Million USD | -129.2% |
| Zhongchao Inc. | 808.15 Thousand USD | -75886.567% |
| Accolade, Inc. | 241.64 Million USD | -154.126% |
| Streamline Health Solutions, Inc. | 10.56 Million USD | -5711.944% |
| Ontrak, Inc. | 1.68 Million USD | -36258.2% |
| SOPHiA GENETICS SA | 18.6 Million USD | -3201.382% |
| R1 RCM Inc. | 1.74 Billion USD | 64.716% |
| Spok Holdings, Inc. | 11.08 Million USD | -5439.329% |
| Privia Health Group, Inc. | 8.28 Million USD | -7308.493% |
| EUDA Health Holdings Limited | 3.37 Million USD | -18097.82% |
| HeartBeam, Inc. | - USD | -Infinity% |
| GeneDx Holdings Corp. | 119.77 Million USD | -412.724% |
| TruBridge, Inc. | 203.28 Million USD | -202.077% |
| Nutex Health, Inc. | 275.75 Million USD | -122.692% |
| Renalytix Plc | 8.53 Million USD | -7094.962% |
| Sharecare, Inc. | 2.34 Million USD | -26087.207% |
| Health Catalyst, Inc. | 249.06 Million USD | -146.555% |
| 10x Genomics, Inc. | 95.37 Million USD | -543.903% |
| GoodRx Holdings, Inc. | 711.07 Million USD | 13.639% |
| SCWorx Corp. | 90.35 Thousand USD | -679511.328% |
| Schrödinger, Inc. | 127.88 Million USD | -380.2% |
| HealthEquity, Inc. | 933.14 Million USD | 34.191% |
| HealthStream, Inc. | 23.22 Million USD | -2544.546% |
| MSP Recovery, Inc. | 679.32 Million USD | 9.603% |
| Augmedix, Inc. | 25.84 Million USD | -2275.958% |
| BrightSpring Health Services, Inc. Common Stock | 3.67 Billion USD | 83.27% |
| Ontrak, Inc. | 1.68 Million USD | -36258.2% |
| SHL Telemedicine Ltd. | 19.85 Million USD | -2993.478% |
| CareCloud, Inc. | 14.73 Million USD | -4068.126% |
| Premier, Inc. | 126 Million USD | -387.369% |
| Certara, Inc. | 298.19 Million USD | -105.938% |
| GeneDx Holdings Corp. | 119.77 Million USD | -412.724% |
| OneMedNet Corporation | 5.1 Million USD | -11937.874% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 3.67 Billion USD | 83.27% |
| EUDA Health Holdings Limited | 3.37 Million USD | -18097.82% |
| HeartBeam, Inc. | - USD | -Infinity% |
| CareCloud, Inc. | 14.73 Million USD | -4068.126% |
| Mangoceuticals, Inc. | 128.67 Thousand USD | -477129.985% |
| CareMax, Inc. | 491.93 Million USD | -24.832% |
| Healthcare Triangle, Inc. | 4.31 Million USD | -14124.925% |
| National Research Corporation | 38.95 Million USD | -1476.368% |
| Aclarion, Inc. | 1.12 Million USD | -54450.671% |
| OptimizeRx Corporation | 36.82 Million USD | -1567.644% |